Bird & Bird LLP

Well regarded for its ‘full-service life sciences practice’, Bird & Bird LLP advises global pharma, biotech and medical devices clients on high-value, multijurisdictional patent litigation, on both the innovator and generic sides. The team’s capabilities extend to corporate and commercial transactions as well as regulatory matters, including data protection and exclusivity, clinical trials, marketing authorisations, and advertising. The team is co-led by Mark Hilton, who specialises in life sciences patent litigation, and Brussels-based regulatory expert Marc Martens. Sally Shorthose focuses on the protection and exploitation of IP rights in transactions, while James Baillieu is experienced in M&A and VC fundraising. Morag Macdonald and Nicole Jadeja further strengthen the team with their experience in IP advisory and litigation. Robert Williams is no longer at the firm.